During longitudinal MRD assessments in pediatric B-ALL patients, we observed that isolated CLCs (CD19(+)/TdT(+)) showed different immunophenotypes based on their CD10/CD34 status. This evidence concerns the gene MME and precursor B-cell acute lymphoblastic leukemia.